John Merrill
Family Medicine · Clarkston, WANPI 1992152326
Payments from drug & device makers
Across 44 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$258
- Tandem Diabetes Care, Inc.$83
- Pfizer$64
- Merck$50
- Bayer$42
- Boehringer Ingelheim$41
- plus $372 from 17 others
What the payments were for
- Food & beverage$912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $258 |
| Tandem Diabetes Care, Inc. | 2 | $83 |
| Pfizer | 4 | $64 |
| Merck | 2 | $50 |
| Bayer | 2 | $42 |
| Boehringer Ingelheim | 2 | $41 |
| GSK | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Exact Sciences | 1 | $34 |
| Eisai Inc. | 1 | $28 |
| Lilly USA, LLC | 2 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Medtronic | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Amgen | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
How this compares
$912 in reported general payments places this provider in the 80th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 119 | $146,170 |
| OzempicSemaglutide | 60 | $63,500 |
| JardianceEmpagliflozin | 43 | $53,934 |
| CreonLipase/Protease/Amylase | 15 | $47,181 |
| Dupixent SyringeDupilumab | 11 | $43,676 |
| Bydureon BciseExenatide Microspheres | 17 | $26,138 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $20,690 |
| JanuviaSitagliptin Phosphate | 26 | $20,520 |
| XareltoRivaroxaban | 21 | $20,077 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $18,556 |
| FarxigaDapagliflozin Propanediol | 14 | $12,814 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $8,091 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $6,834 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 245 | $6,578 |
| Losartan Potassium | 694 | $6,143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $146,170119 claims |
| Novo NordiskOzempic | $15 | $63,50060 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $41 | $60,76957 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $258 | $20,90626 claims |
| MerckJanuvia | $50 | $20,52026 claims |
| Johnson & JohnsonXarelto | $22 | $20,07721 claims |
| GSKTrelegy Ellipta | $40 | $18,55622 claims |
| Lilly USA, LLCHumalog | $25 | $1,77812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Clarkston
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
- Kevin HatfieldSeattle$527K
- Steven SmithAuburn$438K
- John RobinsonEdmonds$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.